Perpetual Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$855K Sell
3,254
-1,400
-30% -$375K 0.1% 123
2022
Q3
$1.05M Hold
4,654
0.15% 102
2022
Q2
$1.13M Sell
4,654
-700
-13% -$172K 0.17% 109
2022
Q1
$1.29M Hold
5,354
0.16% 118
2021
Q4
$1.2M Buy
5,354
+700
+15% +$148K 0.14% 120
2021
Q3
$990K Hold
4,654
0.13% 129
2021
Q2
$1.13M Buy
4,654
+900
+24% +$221K 0.16% 121
2021
Q1
$931K Hold
3,754
0.15% 94
2020
Q4
$853K Buy
+3,754
New +$866K 0.13% 115

Other funds holding AMGN

Perpetual Investment Management's AMGN Position: Q4 2022 in Review

Perpetual Investment Management reduced its Amgen (AMGN) stake by 30% in Q4 2022, selling an estimated $375K and leaving 3,254 shares worth $855K. The position accounts for 0.1% of the portfolio, ranked #123.

Perpetual Investment Management first reported a position in AMGN in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.29M in Q1 2022. 2,500 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Perpetual Investment Management held 3,254 shares of Amgen worth $855K as of Q4 2022.
  • Perpetual Investment Management sold 1,400 Amgen shares in Q4 2022, an estimated $375K.
  • Amgen made up 0.1% of Perpetual Investment Management's portfolio in Q4 2022, its #123 holding.
  • Perpetual Investment Management first reported a position in Amgen in Q4 2020 and has held it in 9 quarters since.
  • Perpetual Investment Management's Amgen position peaked at $1.29M in Q1 2022.
  • 2,500 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Perpetual Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.